Risk factors for chronic graft-versus-host disease after anti-thymocyte globulin-based haploidentical hematopoietic stem cell transplantation in acute myeloid leukemia

{{article.zuoZheEn}}

PDF(533 KB)
PDF(533 KB)
Front. Med. ›› 2019, Vol. 13 ›› Issue (6) : 667-679. DOI: 10.1007/s11684-019-0702-z
RESEARCH ARTICLE

Risk factors for chronic graft-versus-host disease after anti-thymocyte globulin-based haploidentical hematopoietic stem cell transplantation in acute myeloid leukemia

  • {{article.zuoZheEn}}
Author information +
History +

Highlights

{{article.highlightEn}}

Abstract

{{article.abstractEn}}

Author summary

{{article.authorSummayEn}}

Keywords

Cite this article

Download citation ▾
{{article.zuoZheEn_L}}. {{article.titleEn}}. Front. Med., 2019, 13(6): 667‒679 https://doi.org/10.1007/s11684-019-0702-z

References

References

{{article.reference}}

RIGHTS & PERMISSIONS

{{article.copyright.year}} {{article.copyright.holder}}
PDF(533 KB)

Accesses

Citations

Detail

Sections
Recommended

/